儿童胸部淋巴瘤的钆增强成像:静脉对比剂真的必要吗?
该单中心回顾性研究纳入51例25岁以下胸部淋巴瘤患者,对比无增强与增强MRI对胸部淋巴结的评估,发现两者对可疑与非可疑淋巴结判读一致性高(κ=0.81),仅纵隔淋巴结测量差异有统计学意义但仅1 mm,作者结论认为年轻胸部淋巴瘤患者可安全不使用对比剂完成MRI。
要点
- 无增强与增强序列对可疑及非可疑胸部淋巴结判读一致性高(κ=0.81)。
- 仅纵隔淋巴结测量差异有统计学意义(p<0.001),但差异仅1 mm。
- 作者结论认为年轻胸部淋巴瘤患者可安全不使用钆对比剂完成MRI。
核心结论
- 年轻胸部淋巴瘤患者的MRI可安全地不使用对比剂完成。
研究设计与样本
- 单中心回顾性研究,纳入25岁以下经组织病理学检查胸部淋巴结且至少行一次含无增强与增强序列胸部MRI的患者51例(平均年龄16.0±3.7岁)。
关键影像表现/征象
- 判为可疑的淋巴结大多位于纵隔站(86.4%)。
- 无增强与增强序列对可疑和非可疑淋巴结判读一致性高(κ=0.81)。
- 仅纵隔淋巴结测量差异有统计学意义(p<0.001),差异小(1 mm),其余比较p>0.05。
诊断标准与关键数值
- 可疑淋巴结标准:直径>1 cm、圆形、坏死、侵犯周围结构;非可疑为不符合上述标准。
- 评估7个胸部淋巴结站,包括纵隔、肺门、锁骨上区和腋窝区域,由两名阅片者评估病灶直径、数目、形态、坏死及周围结构侵犯。
临床应用与阅片要点
- 作者结论认为年轻胸部淋巴瘤患者可安全不使用钆对比剂完成MRI。
- 五种不同对比剂类型的使用未显示显著差异(最小p=0.08)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Increasing awareness of potential side effects from gadolinium-based contrast agents has underlined the need for contrast-free magnetic resonance imaging (MRI). Numerous recent articles evaluated the risk of potential brain deposits, with the result that research is putting the focus more on alternative unenhanced imaging techniques. The aim of this study was to determine the need for contrast media for chest MRI in primary staging and follow-up care of lymphoma.
METHODS: This monocentric, retrospective study encompassed patients under 25 years of age who had undergone histopathological examination of thoracic lymph nodes and at least one chest MRI examination with unenhanced and contrast-enhanced sequences. Seven different thoracic lymph node stations including mediastinal, hilar, periclavicular, and axillary regions were evaluated by two readers regarding lesion diameter, number, shape, necrosis, and infiltration of surrounding structures. Findings were categorized into suspicious (> 1 cm; round; necrosis; infiltration) or non-suspicious.
RESULTS: Fifty-one patients (mean age, 16.0 ± 3.7 yrs) with thoracic Hodgkin (70.6%) and non-Hodgkin lymphoma (25.5%) and lymphadenopathy (3.9%) were retrospectively included. Most lymph nodes categorized as suspicious were located in the mediastinal station (86.4%). High agreement (κ = 0.81) between unenhanced and contrast-enhanced sequences was found for both suspicious and non-suspicious lymph nodes. Significant (p < 0.001), but small difference (1 mm) was observed only in sizing mediastinal lymph nodes (all other p > 0.05). No significant difference (smallest p = 0.08) was shown for the use of five different types of contrast media.
CONCLUSION: MRI in young patients with thoracic lymphoma can safely be done without the use of contrast agent.
KEY POINT: • Thoracic magnetic resonance imaging in young lymphoma patients can safely be done without gadolinium-based contrast agents.
引用
- Arendt CT, Beeres M, Leithner D, et al. Gadolinium-enhanced imaging of pediatric thoracic lymphoma: is intravenous contrast really necessary? Eur Radiol. 2018. PMID: 30547199. doi:10.1007/s00330-018-5859-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。